What urine protein to creatinine (P/C) ratio is diagnostic for pre-eclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Urine Protein to Creatinine Ratio for Pre-eclampsia

A urine protein to creatinine (P/C) ratio of ≥30 mg/mmol (0.3 mg/mg) is diagnostic for significant proteinuria in pre-eclampsia according to current guidelines. 1

Understanding Proteinuria Assessment in Pre-eclampsia

Proteinuria assessment is a critical component in the evaluation of pregnant women with suspected pre-eclampsia. While proteinuria is no longer required for the diagnosis of pre-eclampsia, its presence helps confirm the diagnosis and may correlate with disease severity.

Diagnostic Thresholds:

  • Spot urine P/C ratio threshold: ≥30 mg/mmol (0.3 mg/mg) 1
  • 24-hour urine protein threshold: ≥300 mg/24 hours 1
  • Dipstick threshold: ≥1+ (approximately 30 mg/dL) 1

Clinical Application and Interpretation

Preferred Testing Method:

  • Initial screening: Automated dipstick urinalysis (when available) 1
  • Confirmation: Spot urine P/C ratio if dipstick is positive (≥1+) 1
  • Gold standard: 24-hour urine protein collection (≥300 mg/24h), though this is being increasingly replaced by spot P/C ratio due to convenience and rapid results 1

Important Clinical Considerations:

  1. Reliability of negative results: A negative dipstick test can generally be accepted without further testing at that time 1

  2. Limitations of P/C ratio:

    • Small number of proteinuric cases may be missed by negative dipstick test 1
    • P/C ratio <30 mg/mmol occasionally gives false-negative results, but in such cases total protein excretion is usually <400 mg/day 1
    • P/C measurements are unreliable in the immediate postpartum period regardless of delivery mode 2
  3. Correlation with disease severity:

    • Massive proteinuria (>5 g/24h) is associated with more severe neonatal outcomes 1
    • Spot P/C ratio >900 mg/mmol (or >500 mg/mmol if age >35 years) is associated with worse maternal outcomes 1

Special Circumstances

Gestational Proteinuria:

  • New onset of proteinuria in pregnancy without other features of pre-eclampsia
  • Requires monitoring as it may be the first sign of developing pre-eclampsia 1

Nephrotic Syndrome:

  • 24-hour urine collection is still indicated to confirm nephrotic syndrome, which has implications for thromboprophylaxis 1

Postpartum Assessment:

  • The standard 0.3 mg/mg threshold is unreliable in the immediate postpartum period due to physiologic proteinuria after delivery 2
  • Both vaginal and cesarean deliveries show significant increases in proteinuria postpartum 2

Diagnostic Algorithm

  1. Initial assessment: Perform automated dipstick urinalysis

    • If negative → No further testing needed at that time
    • If positive (≥1+) → Proceed to spot P/C ratio testing
  2. Spot P/C ratio testing:

    • If ≥30 mg/mmol (0.3 mg/mg) → Significant proteinuria confirmed
    • If <30 mg/mmol but clinical suspicion remains high → Consider 24-hour collection
  3. 24-hour urine collection (when needed):

    • Indicated for suspected nephrotic syndrome
    • Gold standard but being replaced by spot P/C ratio in most clinical scenarios
    • Significant if ≥300 mg/24 hours

By following this evidence-based approach to proteinuria assessment, clinicians can accurately diagnose pre-eclampsia and implement appropriate management to reduce maternal and fetal morbidity and mortality.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.